.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Julphar
Boehringer Ingelheim
McKesson
Baxter
Accenture
Medtronic
Citi
Argus Health
QuintilesIMS
McKinsey

Generated: January 23, 2018

DrugPatentWatch Database Preview

Drug Master Files for: cefdinir

« Back to Dashboard


DMF No. Status Type Submission Date Holder Subject
8489III3/28/1990ASTELLAS PHARMA INCCEPHALOSPORIN (ORAL) (FK482 CEFDINIR, CI-983)
17705AII9/24/2004LUPIN LTDCEFDINIR MONOHYDRATE USP
17986AII12/1/2004OLON SPACEFDINIR HYDRATE
18457AII6/27/2005SANDOZ GMBHCEFDINIR
19401AII5/2/2006ORCHID PHARMA LTDCEFDINIR FORM-B
19607AII7/11/2006AUROBINDO PHARMA LTDCEFDINIR USP (CRYSTAL B)
19866III10/13/2006RANBAXY LABORATORIES LTDCEFDINIR
20730AII6/28/2007TEVA PHARMACEUTICAL INDUSTRIES LTDCEFDINIR HYDRATE
25570AII12/29/2011NECTAR LIFESCIENCES LTDCEFDINIR USP
25882AII3/19/2012COVALENT LABORATORIES PRIVATE LTDCEFDINIR USP
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.


Drug Master File Glossary

STATUS OF DMFS

  • A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
  • I = Inactive
  • N = Not an assigned number
  • P = DMF Pending Filing Review

TYPES OF DMFs

  • Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
  • Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
  • Type III Packaging Material
  • Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
  • Type V FDA Accepted Reference Information

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
McKinsey
Dow
Federal Trade Commission
Healthtrust
AstraZeneca
Citi
Queensland Health
QuintilesIMS
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot